Simplifying Global Compliance
FDAnews Drug Daily Bulletin
German CMO Warned: Poor Training Led to Employee ‘Performance Lapses’
Jan. 22, 2013
Improper staff training at Hameln Pharmaceuticals’ new state-of-the-art, sterile plant in Hameln, Germany, has given rise to employee “performance lapses,” a recently posted warning letter states. These lapses caused “significant violations” of good manufacturing practice regulations, it adds.
Washington Drug Letter
Copyright ©2018. All Rights Reserved.
Design, CMS, Hosting & Web Development :: ePublishing